首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >pKI values of prazosin and idazoxan for receptors stimulated by neuronally released transmitter in the epididymal portion of rat isolated vas deferens.
【2h】

pKI values of prazosin and idazoxan for receptors stimulated by neuronally released transmitter in the epididymal portion of rat isolated vas deferens.

机译:在大鼠离体输精管附睾的神经元释放递质刺激的受体上哌唑嗪和伊达唑烷的pKI值。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. A new method has been used to measure pKI values of prazosin and idazoxan against neuronally-released transmitter in the epididymal portion of the rat isolated vas deferens. The most reproducible results were obtained with a prolonged antagonist equilibration time (1 h). 2. Under these conditions the pKI of prazosin was practically unaffected by addition of alpha, beta-methylene-adenosine-5'-triphosphate (10 microM) to desensitize purinoceptors. Addition of desmethylimipramine (DMI) (0.3 microM) produced a small, but statistically non-significant, reduction. 3. The same method has been used to measure the pKI of prazosin against exogenous noradrenaline. In the latter case addition of DMI (0.3 microM) and corticosterone (30 microM) together produced a statistically significant reduction in the apparent pKI of prazosin. 4. The new method for estimating pKI values shows that DMI itself acts either pseudo-irreversibly or non-competitively and may be reducing the apparent pKI of prazosin. 5. The pKI values obtained for prazosin and idazoxan against neuronally-released transmitter are in good agreement with those obtained by other workers for the actions of these drugs on alpha-adrenoceptors.
机译:1.一种新方法已用于测量大鼠离体输精管附睾部分神经元释放递质的哌唑嗪和伊达唑烷的pKI值。延长的拮抗剂平衡时间(1小时)可获得最可重复的结果。 2.在这些条件下,通过添加α,β-亚甲基-腺苷-5'-三磷酸酯(10 microM)使嘌呤受体脱敏,哌唑嗪的pKI实际上不受影响。加入去甲基丙咪嗪(DMI)(0.3 microM)的效果虽然很小,但在统计学上并不显着。 3.已使用相同的方法来测量哌唑嗪对外源性去甲肾上腺素的pKI。在后一种情况下,将DMI(0.3 microM)和皮质酮(30 microM)加在一起,会使哌唑嗪的表观pKI降低至统计上显着。 4.估算pKI值的新方法表明,DMI本身要么是拟不可逆的,要么是非竞争性的,并且可能会降低哌唑嗪的表观pKI值。 5.对于神经药性释放的递质,哌唑嗪和伊达唑烷的pKI值与其他工作者针对这些药物对α-肾上腺素受体的作用而获得的pKI值非常吻合。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号